Evelo Biosciences, Inc.
EVLO
$0.0003
-$0.0002-40.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -75.00% | -91.72% | -30.68% | -29.95% | -28.02% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -48.87% | -21.53% | -25.33% | 40.54% | 65.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -73.82% | -88.39% | -30.25% | -27.39% | -26.13% |
|
|
|||||
| Total Current Assets | -73.82% | -88.39% | -30.25% | -27.39% | -26.13% |
| Net Property, Plant & Equipment | -93.04% | -40.78% | -26.21% | -24.61% | -25.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -31.06% | 23.12% | 0.09% | -11.81% | -16.95% |
| Total Assets | -76.11% | -81.40% | -28.65% | -26.66% | -25.87% |
|
|
|||||
| Total Accounts Payable | -66.06% | 67.48% | -13.98% | 10.18% | -38.42% |
| Total Accrued Expenses | -63.54% | -50.58% | -3.75% | -39.20% | -19.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 176.63% | 480.17% | 1,091.35% | 15.79% | 553.81% |
| Total Finance Division Other Current Liabilities | 19.45% | -97.29% | -83.46% | -42.45% | -30.83% |
| Total Other Current Liabilities | 19.45% | -97.29% | -83.46% | -42.45% | -30.83% |
| Total Current Liabilities | 47.72% | 159.04% | 253.99% | -28.61% | 29.86% |
|
|
|||||
| Total Current Liabilities | 47.72% | 159.04% | 253.99% | -28.61% | 29.86% |
| Long-Term Debt | -- | -- | -- | -6.32% | -21.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -40.97% | -36.25% | -32.37% | -29.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.97% | 0.37% | 0.43% | 8.79% | -3.39% |
| Total Liabilities | -38.53% | -12.21% | -8.29% | -12.34% | -7.65% |
|
|
|||||
| Common Stock & APIC | 8.99% | 3.68% | 23.24% | 23.83% | 22.88% |
| Retained Earnings | -16.28% | -21.16% | -24.75% | -27.62% | -30.99% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -386.13% | -229.39% | -63.00% | -157.60% | -71.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -386.13% | -229.39% | -63.00% | -157.60% | -71.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -386.13% | -229.39% | -63.00% | -157.60% | -71.78% |
|
|
|||||